Delcath Systems enters new employment agreements with CEO Michel, SVP Pennell, and GM Muir

DELCATH SYSTEMS, INC.

CEO Michel's new agreement provides for 15 months severance (18 months if change in control) and performance bonus eligibility.
SVP Finance Pennell's agreement provides for 12 months severance (12 months if change in control) and bonus eligibility.
GM Oncology Muir's agreement provides for 12 months severance (12 months if change in control) and bonus eligibility.
These agreements replace prior agreements and include standard non-disclosure, non-solicitation, and non-disparagement provisions.
No changes in roles or base salary amounts disclosed; executives continue in current positions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.